Skip to main content
Log in

131-Iodine capsules in thyroid therapy: An individually controlled study of their uptake kinetics as compared to liquid 131-Iodine

  • Published:
European Journal of Nuclear Medicine Aims and scope Submit manuscript

Abstract

We investigated the uptake of therapeutic doses of 131-Iodine in capsular form which were given to 16 patients with benign thyroid disease, and compared it to the uptake of a diagnostic dose of liquid 131-Iodine given to the same patients. The aim of this study was to determine the additional radiation dose sustained by the gastric mucosa, and thus, to establish the safety of this galenic form of 131I. It was found that the average capsule-dissolution time was about 12 min, with a large standard deviation of about 7 min. Using these data and a theoretical radiation-dose calculation, we estimated that the maximum dose to the gastric mucosa was approximately 250 rad (250 cGy) for a therapeutic activity of 5 mCi (185 MBq), which is the maximum dose which may be given as single application to out-patients in Switzerland. Thus, 131I administered in capsular form is a safe galenic form for therapeutic use in patients with thyroid disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Havlik E, Bergmann H, Correns H-J, Schuerer M, Hoefer R (1979) Untersuchungen zur Strahlenbelastung bei Radiojodtherapie mit Gelatinekapseln. Nuklearmedizin (Suppl) 16:710–714

    Google Scholar 

  2. Loevinger R, Japha EM, Brownell GL (1956) Discrete radioisotope sources. In: Hine GJ, Brownell GL (eds) Radiation dosimetry. Academic Press, New York, p 693–731

    Google Scholar 

  3. Moser E, Raithel E, Haag A (1983) In vivo Untersuchungen zum intestinalen Löslichkeits- und Resorptionsverhalten von kommerziell gefertigten Natriumjodid-(131I)-Therapiekapseln. Nucl Compact 14:200–207

    Google Scholar 

  4. Mueller-Brand J, Schaub JJ, Moegelen C, Peyer P (1978) Der Einfluess der galenischen Applikationsform der 131I auf das Radiojodstudium. Nuklearmedizin 17:70–73

    Google Scholar 

  5. Schuerer M, Jackisch N, Lincke H-J, Buchali K, Correns H-J (1981) Radiation protection aspects using 131-Iodine sodium iodine capsules for radioiodine therapy. Nucl Compact 12:148–152

    Google Scholar 

  6. Uehlinger E (1976) Spezielle pathologische Anatomie. Springer, Berlin Heidelberg New York, p 137

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Dedicated to Prof. Hans Boersch on the occasion of his 75th birthday

Rights and permissions

Reprints and permissions

About this article

Cite this article

von Schulthess, G.K., Seelentag, W.W., Pfeiffer, G. et al. 131-Iodine capsules in thyroid therapy: An individually controlled study of their uptake kinetics as compared to liquid 131-Iodine. Eur J Nucl Med 10, 25–28 (1985). https://doi.org/10.1007/BF00261758

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00261758

Keywords

Navigation